PCP
BLCM

Proficio Capital Partners’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Proficio Capital Partners’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-85
Closed -$1K – 1703
2019
Q2 		$1K Buy
85
+65
+325% +$1.76K ﹤0.01% 1861
2019
Q1 		$1K Buy
+20
New +$668 ﹤0.01% 1632

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Proficio Capital Partners's BLCM Position: Q3 2019 in Review

Proficio Capital Partners sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 85 shares — an estimated $1K sold.

Proficio Capital Partners first reported a position in BLCM in Q1 2019 and held it in 2 quarters. The position peaked at $1K in Q2 2019. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Proficio Capital Partners reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 85 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $1K.
  • Proficio Capital Partners first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Bellicum Pharmaceuticals, Inc. position peaked at $1K in Q2 2019.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.